GlassScriptPhysician profile
Emily Ferullo
NPI 1144945429
$662.30
in general payments reported to CMS, 2019-2025
15 companies · $46.26 in 2025
The $46.26 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $260 · 2024: $356 · 2025: $46.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $115.35 | 2023-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $103.89 | 2023-2024 | Lifevest |
| Abbvie INC. | $90.76 | 2024 | |
| Amgen INC. | $48.21 | 2023-2024 | Prolia, Evenity, Repatha |
| Atricure, INC. | $46.26 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Astrazeneca Pharmaceuticals LP | $40.56 | 2024 | Farxiga, Airsupra |
| Lilly USA, LLC | $34.16 | 2024 | Mounjaro |
| Glaxosmithkline, LLC. | $32.97 | 2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Exact Sciences Corporation | $28.70 | 2024 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.46 | 2024 | Xifaxan |
| Merck Sharp & Dohme LLC | $28.35 | 2023 | Keytruda |
| Haemonetics Corporation | $17.70 | 2023 | Teg5000 Hemostasis Analyzer |
| Otsuka America Pharmaceutical, INC. | $16.56 | 2024 | Rexulti |
| Pfizer INC. | $15.36 | 2024 | |
| Xeris Pharmaceuticals, INC. | $15.01 | 2024 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Ferullo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.